The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1327
December 14, 2009
View Complete Issue         Table of Contents 2019 
Rapid-Acting Insulin Analogues
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Rapid-Acting Insulin Analogues
December 14, 2009 (Issue: 1327)
Three rapid-acting insulin analogs are currently available: insulin lispro, insulin aspart and insulin glulisine. 1-3 All three are approved for use in both type 1 and type 2 diabetes, either by subcutaneous injection, insulin pump or intravenous...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Rapid-Acting Insulin Analogues
Article code: 1327b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.